$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

$scnd Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000165495422013054 Filed on September 28, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$2.670M	$2.777M	$11.40M
YoY Change	-6.46%	9.76%	16.63%
Cost Of Revenue	$1.321M	$1.509M	$5.664M
YoY Change	-1.49%	9.33%	18.0%
Gross Profit	$1.349M	$1.268M	$5.737M
YoY Change	-10.87%	10.27%	15.3%
Gross Profit Margin	50.53%	45.65%	50.32%
Selling, General & Admin	$2.483M	$2.688M	$10.13M
YoY Change	3.4%	-9.17%	25.64%
% of Gross Profit	184.06%	212.04%	176.54%
Research & Development	$560.1K	$732.0K	$2.873M
YoY Change	-12.0%	22.04%	76.95%
% of Gross Profit	41.52%	57.74%	50.09%
Depreciation & Amortization	$188.9K	$106.4K	$688.2K
YoY Change	14.42%	-14.74%	173.64%
% of Gross Profit	14.0%	8.39%	12.0%
Operating Expenses	$3.043M	$3.420M	$13.00M
YoY Change	0.17%	-3.91%	34.25%
Operating Profit	-$1.694M	-$2.153M	-$7.264M
YoY Change	11.14%	-10.68%	54.26%
Interest Expense		$27.50K	$77.30K
YoY Change		154.63%	-5.96%
% of Operating Profit
Other Income/Expense, Net	$15.00K	-$178.4K	$618.9K
YoY Change	-149.02%	-132.48%	8.28%
Pretax Income	-$1.709M	-$2.303M	-$7.002M
YoY Change	11.54%	24.52%	72.67%
Income Tax	-$417.2K	-$298.3K	-$1.349M
% Of Pretax Income
Net Earnings	-$1.292M	-$2.004M	-$5.644M
YoY Change	6.88%	47.24%	53.69%
Net Earnings / Revenue	-48.39%	-72.17%	-49.51%
Basic Earnings Per Share
Diluted Earnings Per Share	-$184.5K	-$289.7K	-$850.4K
COMMON SHARES
Basic Shares Outstanding	7.004M shares	7.004M shares
Diluted Shares Outstanding	7.004M shares	7.004M shares	6.637M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.736M	$9.363M	$9.363M
YoY Change	-36.87%	-30.23%	-30.23%
Cash & Equivalents	$2.438M	$2.971M	$2.971M
Short-Term Investments	$5.299M	$6.392M	$6.392M
Other Short-Term Assets	$510.4K	$547.8K	$547.8K
YoY Change	-8.58%	34.86%	34.86%
Inventory	$4.956M	$4.696M	$4.696M
Prepaid Expenses
Receivables	$1.141M	$1.501M	$1.501M
Other Receivables	$161.4K	$161.1K	$161.1K
Total Short-Term Assets	$14.51M	$16.27M	$16.27M
YoY Change	-16.95%	-11.73%	-11.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.066M	$1.006M	$2.481M
YoY Change	144.93%	143.72%	130.18%
Goodwill	$4.395M	$4.395M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$62.40K	$62.40K	$3.806M
YoY Change	15.13%	14.92%	49.6%
Total Long-Term Assets	$13.07M	$12.76M	$12.76M
YoY Change	21.61%	20.68%	20.68%
TOTAL ASSETS
Total Short-Term Assets	$14.51M	$16.27M	$16.27M
Total Long-Term Assets	$13.07M	$12.76M	$12.76M
Total Assets	$27.58M	$29.03M	$29.03M
YoY Change	-2.26%	0.09%	0.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$452.8K	$1.106M	$1.106M
YoY Change	-27.03%	143.86%	143.86%
Accrued Expenses	$762.5K	$796.0K	$1.095M
YoY Change	40.5%	25.65%	-18.13%
Deferred Revenue
YoY Change
Short-Term Debt	$84.00K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.584M	$2.230M	$2.230M
YoY Change	-20.58%	-2.48%	-2.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.219M	$0.00	$1.240M
YoY Change		-100.0%	150.53%
Total Long-Term Liabilities	$1.219M	$0.00	$1.240M
YoY Change		-100.0%	150.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.584M	$2.230M	$2.230M
Total Long-Term Liabilities	$1.219M	$0.00	$1.240M
Total Liabilities	$2.802M	$3.470M	$3.470M
YoY Change	12.7%	24.74%	24.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.588M	-$6.296M
YoY Change	307.95%	866.9%
Common Stock	$32.63M	$32.02M
YoY Change	18.18%	18.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$52.40K	$52.40K
YoY Change	0.0%	0.0%
Treasury Stock Shares	19.80K shares	19.80K shares
Shareholders Equity	$24.77M	$25.56M	$25.56M
YoY Change
Total Liabilities & Shareholders Equity	$27.58M	$29.03M	$29.03M
YoY Change	-2.26%	0.09%	0.09%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$1.292M	-$2.004M	-$5.644M
YoY Change	6.88%	47.24%	53.69%
Depreciation, Depletion And Amortization	$188.9K	$106.4K	$688.2K
YoY Change	14.42%	-14.74%	173.64%
Cash From Operating Activities	-$1.466M	-$1.817M	-$5.512M
YoY Change	32.35%	156.22%	66.95%
INVESTING ACTIVITIES
Capital Expenditures	$160.1K	-$420.2K	$757.6K
YoY Change	227.4%	2701.33%	-481.28%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$1.027M	$1.220M	-$2.992M
YoY Change	-131.36%	-119.97%	-72.0%
Cash From Investing Activities	$866.6K	$799.3K	-$3.749M
YoY Change	-126.08%	-113.06%	-65.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$84.00K	-98.80K	$2.628M
YoY Change		-100.62%	-83.88%
NET CHANGE
Cash From Operating Activities	-$1.466M	-1.817M	-$5.512M
Cash From Investing Activities	$866.6K	799.3K	-$3.749M
Cash From Financing Activities	$84.00K	-98.80K	$2.628M
Net Change In Cash	-$533.4K	-1.116M	-$6.704M
YoY Change	-87.96%	-112.32%	-415.53%
FREE CASH FLOW
Cash From Operating Activities	-$1.466M	-$1.817M	-$5.512M
Capital Expenditures	$160.1K	-$420.2K	$757.6K
Free Cash Flow	-$1.626M	-$1.396M	-$6.270M
YoY Change	40.59%	101.21%	102.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2170400	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	55300	usd
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	39600	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1342700	usd
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	767100	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4696300	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.25	pure
CY2022	scnd	Operating Lease Weighted Average Remaining Lease Terms OperatingLeaseWeightedAverageRemainingLeaseTerms	P5Y11M1D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions	0.05	pure
CY2022	us-gaap	Payments For Rent PaymentsForRent	344500	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	333900	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	288700	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	264300	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	262700	usd
CY2022Q2	scnd	Thereafter Thereafter	338900	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1781600	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	242700	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1538900	usd
CY2021Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	7880100	usd
CY2021Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4138100	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	159200	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	187500	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	25400	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	40200	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets	800300	usd
CY2021Q2	scnd	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Trade Name BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTradeName	452300	usd
CY2021Q2	scnd	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Non Compete Agreements BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredNonCompeteAgreements	784500	usd
CY2021Q2	scnd	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Ip Rand D BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredIPRandD	742100	usd
CY2021Q2	scnd	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Customer Relationships BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredCustomerRelationships	252200	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	286200	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	3931000	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	39300	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	90300	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	59400	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	189000	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	3742000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1501400	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000087802
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15600	usd
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	19802	shares
CY2020Q2	scnd	Paid To The Sellers PaidToTheSellers	358000	usd
CY2022	scnd	Dilutive Securities1 DilutiveSecurities1	0	shares
CY2021	scnd	Dilutive Securities1 DilutiveSecurities1	0	shares
CY2022	scnd	Number Of Options Exercised NumberOfOptionsExercised	0	shares
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-6658
CY2022	dei	Entity Registrant Name EntityRegistrantName	SCIENTIFIC INDUSTRIES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2217279
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	80 Orville Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 102
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Bohemia
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11716
CY2022	dei	City Area Code CityAreaCode	631
CY2022	dei	Local Phone Number LocalPhoneNumber	567-4700
CY2022	dei	Security12g Title Security12gTitle	Common stock, $.05 par value
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	16329100	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7003599	shares
CY2022	dei	Auditor Firm AuditorFirmId	103
CY2022	dei	Auditor Name AuditorName	Nussbaum Berg Klein & Wolpow, CPAs LLP
CY2022	dei	Auditor Location AuditorLocation	Melville, New York
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2971100	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9675200	usd
CY2022Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	6391600	usd
CY2021Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	3744600	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15600	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1294700	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4696300	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	2977100	usd
CY2022Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	161100	usd
CY2021Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	333300	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547600	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	350900	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	200	usd
CY2021Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	55300	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	16269300	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	18431100	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1005600	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	412600	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4395400	usd
CY2021Q2	us-gaap	Goodwill Goodwill	4395400	usd
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2079800	usd
CY2021Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2557800	usd
CY2022Q2	scnd	Deferred Tax Asset Net Noncurrent DeferredTaxAssetNetNoncurrent	3743600	usd
CY2021Q2	scnd	Deferred Tax Asset Net Noncurrent DeferredTaxAssetNetNoncurrent	2489900	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1475500	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	665300	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	62400	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54300	usd
CY2022Q2	us-gaap	Assets Assets	29031600	usd
CY2021Q2	us-gaap	Assets Assets	29006400	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1105900	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	453500	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	796000	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	633500	usd
CY2022Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	29000	usd
CY2021Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	0	usd
CY2022Q2	scnd	Contingent Consideration Payable Current ContingentConsiderationPayableCurrent	0	usd
CY2021Q2	scnd	Contingent Consideration Payable Current ContingentConsiderationPayableCurrent	136600	usd
CY2022Q2	us-gaap	Bank Overdrafts BankOverdrafts	0	usd
CY2021Q2	us-gaap	Bank Overdrafts BankOverdrafts	321700	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	299300	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	270500	usd
CY2022Q2	scnd	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	0	usd
CY2021Q2	scnd	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	433800	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2021Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	37200	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2230200	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2286800	usd
CY2022Q2	scnd	Contingent Consideration Payable Less Current Portion ContingentConsiderationPayableLessCurrentPortion	0	usd
CY2021Q2	scnd	Contingent Consideration Payable Less Current Portion ContingentConsiderationPayableLessCurrentPortion	23400	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1239600	usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	460500	usd
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10900	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3469800	usd
CY2021Q2	us-gaap	Liabilities Liabilities	2781600	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7023401	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6477945	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7003599	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6458143	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	351200	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	324000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31664100	usd
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26613500	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-105600	usd
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9200	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6295500	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-651100	usd
CY2022Q2	us-gaap	Assets Net AssetsNet	25614200	usd
CY2021Q2	us-gaap	Assets Net AssetsNet	26277200	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	19802	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	52400	usd
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	52400	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	25561800	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	26224800	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29031600	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29006400	usd
CY2022	us-gaap	Revenues Revenues	11400500	usd
CY2021	us-gaap	Revenues Revenues	9775200	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	5663800	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	4799800	usd
CY2022	us-gaap	Gross Profit GrossProfit	5736700	usd
CY2021	us-gaap	Gross Profit GrossProfit	4975400	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5816600	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4028500	usd
CY2022	us-gaap	Selling Expense SellingExpense	4310800	usd
CY2021	us-gaap	Selling Expense SellingExpense	4031900	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2873300	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1623800	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	13000700	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9684200	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7264000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4708800	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	185100	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	571600	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	77300	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	82200	usd
CY2022	scnd	Nonoperating Income Expensenet NonoperatingIncomeExpensenet	262400	usd
CY2021	scnd	Nonoperating Income Expensenet NonoperatingIncomeExpensenet	653800	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7001600	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4055000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-99200	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1253600	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-945000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1352800	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-945000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5648800	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3110000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4400	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-562500	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5644400	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3672500	usd
CY2022	scnd	Unrealized Holding Loss On Investment Securities Net Of Tax UnrealizedHoldingLossOnInvestmentSecuritiesNetOfTax	-10200	usd
CY2021	scnd	Unrealized Holding Loss On Investment Securities Net Of Tax UnrealizedHoldingLossOnInvestmentSecuritiesNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-86200	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-9200	usd
CY2022	scnd	Comprehensive Gain ComprehensiveGain	-96400	usd
CY2021	scnd	Comprehensive Gain ComprehensiveGain	-9200	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5740800	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-3681700	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.85
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.97
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.18
CY2022	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.85
CY2021	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-1.15
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	11721400	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3672500	usd
CY2021	scnd	Stock Issued During Period Amount New Issues StockIssuedDuringPeriodAmountNewIssues	16074000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-9200	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3100	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2108000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	26224800	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5644400	usd
CY2022	scnd	Stock Issued During Period Amount New Issues StockIssuedDuringPeriodAmountNewIssues	2727200	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-86200	usd
CY2022	scnd	Unrealized Holding Loss On Investment Securities Net Of Tax UnrealizedHoldingLossOnInvestmentSecuritiesNetOfTax	-10200	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2350600	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	25561800	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5644400	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3672500	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	32700	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-35600	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	233700	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	10400	usd
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-433800	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-531100	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	688200	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	251500	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1253600	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1152500	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	405400	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350600	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2108000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-42500	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-30000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-206700	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-75500	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1719200	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-560000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	810200	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	138000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	172200	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1500	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-207800	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-211400	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	652400	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	79600	usd
CY2022	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	29000	usd
CY2021	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-20000	usd
CY2022	scnd	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	807900	usd
CY2021	scnd	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-105600	usd
CY2022	scnd	Bank Overdraft BankOverdraft	-321700	usd
CY2021	scnd	Bank Overdraft BankOverdraft	278600	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8100	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	0	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	10900	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-10900	usd
CY2022	us-gaap	Increase Decrease In Reserve For Commissions Expense And Taxes IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes	180300	usd
CY2021	us-gaap	Increase Decrease In Reserve For Commissions Expense And Taxes IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes	-195200	usd
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	132500	usd
CY2021	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	371000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5511900	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3301500	usd
CY2022	scnd	Redemption Of Investment Securities Available For Sale RedemptionOfInvestmentSecuritiesAvailableForSale	2709800	usd
CY2021	scnd	Redemption Of Investment Securities Available For Sale RedemptionOfInvestmentSecuritiesAvailableForSale	6181400	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5634500	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	9569000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	440000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7679000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	757600	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	198700	usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	67000	usd
CY2021	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	58700	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3749300	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10884000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	17080400	usd
CY2022	scnd	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	-272800	usd
CY2021	scnd	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	-1006400	usd
CY2022	us-gaap	Payments For Commissions PaymentsForCommissions	98800	usd
CY2021	us-gaap	Payments For Commissions PaymentsForCommissions	168000	usd
CY2022	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	usd
CY2021	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	401100	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3100	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2628400	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16310200	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-71300	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9200	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6704100	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2115500	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9675200	usd
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7559700	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2971100	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9675200	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	2500	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1010900	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
CY2022	scnd	Record Lease Liabilities RecordLeaseLiabilities	1010400	usd
CY2021	scnd	Record Lease Liabilities RecordLeaseLiabilities	0	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, the allowance for doubtful accounts, slow-moving inventory reserves, depreciation and amortization, the fair values of intangibles and goodwill, and provision or benefit for income taxes. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>
CY2022	scnd	Obligation Percentage ObligationPercentage	0.50	pure
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1984300	usd
CY2021Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	8922800	usd
CY2022	scnd	Finite Lived Intangible Assets FiniteLivedIntangibleAssets	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets consist primarily of acquired technology, customer relationships, non-compete agreements, patents, licenses, websites, intellectual property in-process research and development (“IPR&D”), trademarks and trade names. All intangible assets are amortized on a straight-line basis over the estimated useful lives of the respective assets, generally 3 to 10 years. The Company continually evaluates the remaining estimated useful lives of intangible assets that are being amortized to determine whether events or circumstances warrant a revision to the remaining period of amortization.</p>
CY2022	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.050	pure
CY2022	us-gaap	Advertising Expense AdvertisingExpense	628700	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	399700	usd
CY2022Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	6391600	usd
CY2022Q2	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	-140800	usd
CY2021Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	3687300	usd
CY2021Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3744600	usd
CY2022	us-gaap	Reclassifications Reclassifications	<p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Certain balances from fiscal 2021 have been reclassified to conform to the current year presentation.</p>
CY2022	scnd	Description Of New Accounting Pronouncement Not Yet Adopted DescriptionOfNewAccountingPronouncementNotYetAdopted	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated all recent accounting pronouncements as issued by the FASB in the form of Accounting Standards Updates (“ASU”) through the date these financial statements were available to be issued and found no recent pronouncements issued to have a material impact on the financial statements of the Company. The Company continually evaluates ASU’s issued, but not yet effective, to determine whether the ASU will have any material impact on the Company and its operations.</p>
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2971100	usd
CY2022Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	6391600	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	9362700	usd
CY2022Q2	scnd	Contingent Consideration1 ContingentConsideration1	0	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9675200	usd
CY2021Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	3744600	usd
CY2021Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	13419800	usd
CY2021Q2	scnd	Contingent Consideration1 ContingentConsideration1	160000	usd
CY2022Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	6532400	usd
CY2021Q2	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	57300	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	117500	usd
CY2022Q2	scnd	Paid To The Sellers PaidToTheSellers	98800	usd
CY2022Q2	scnd	Unpaid As Account Payable UnpaidAsAccountPayable	18700	usd
CY2021Q2	scnd	Contingent Consideration1 ContingentConsideration1	160000	usd
CY2020Q2	scnd	Contingent Consideration1 ContingentConsideration1	358000	usd
CY2022	scnd	Increase Decrease In Contingent Liabilities IncreaseDecreaseInContingentLiabilities	-42500	usd
CY2021	scnd	Increase Decrease In Contingent Liabilities IncreaseDecreaseInContingentLiabilities	-30000	usd
CY2022	scnd	Payments For Contingent Liabilities PaymentsForContingentLiabilities	-117500	usd
CY2021	scnd	Payments For Contingent Liabilities PaymentsForContingentLiabilities	-168000	usd
CY2022Q2	scnd	Contingent Consideration ContingentConsideration	0	usd
CY2021Q2	scnd	Contingent Consideration ContingentConsideration	160000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3298300	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	2977100	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2088700	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1516300	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1083100	usd
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1103700	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1005600	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	412600	usd
CY2022	us-gaap	Depreciation Depreciation	145300	usd
CY2021	us-gaap	Depreciation Depreciation	104600	usd
CY2022	scnd	Wrote Off Fully Depreciated Assets WroteOffFullyDepreciatedAssets	164600	usd
CY2021	scnd	Wrote Off Fully Depreciated Assets WroteOffFullyDepreciatedAssets	0	usd
CY2022	scnd	Accumulated Depreciated Amount AccumulatedDepreciatedAmount	164600	usd
CY2021	scnd	Accumulated Depreciated Amount AccumulatedDepreciatedAmount	0	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4395400	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4402200	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2322400	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2079800	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4337300	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1779500	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2557800	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	542900	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	146900	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	535900	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	520800	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	485300	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	284400	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	136800	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	116600	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2079800	usd
CY2022	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	7880100	usd
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	201100	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.00
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7580400	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	356400	usd
CY2022Q2	scnd	Lessee Operating Lease Liability Payments Due Yearsix LesseeOperatingLeaseLiabilityPaymentsDueYearsix	270600	usd
CY2022	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	6637471	shares
CY2021	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	3189602	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6637471	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3189602	shares
CY2022	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.85
CY2021	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.97
CY2022	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	-0.00
CY2021	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	-0.18
CY2022	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-0.85
CY2021	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-1.15
CY2022	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	3000000	shares
CY2022Q2	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	7000000	shares
CY2022Q2	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	10000000	shares
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	15000000	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	5000000	shares
CY2022Q1	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	15000000	shares
CY2022Q1	scnd	Common Stock Shares Authorized Increase CommonStockSharesAuthorizedIncrease	20000000	shares
CY2021Q2	scnd	Issuence And Sold Aggregate Shares To Investors IssuenceAndSoldAggregateSharesToInvestors	1595880	shares
CY2021Q2	us-gaap	Share Price SharePrice	4.75
CY2021Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	797940	shares
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.50
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.5
CY2021	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2000000	shares
CY2021Q2	us-gaap	Share Price SharePrice	4.75
CY2021	scnd	Additional Common Stock Purchased Share AdditionalCommonStockPurchasedShare	999993	shares
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1300000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	545456	shares
CY2022Q1	scnd	Additional Common Stock Purchased Share AdditionalCommonStockPurchasedShare	274727	shares
CY2022Q1	us-gaap	Share Price SharePrice	5.50
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	272800	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1193000	shares
CY2022Q2	us-gaap	Option Contract Indexed To Equity Settlement Share Fair Value Per Share OptionContractIndexedToEquitySettlementShareFairValuePerShare	5
CY2022	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	57000	shares
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2022	srt	Financing Receivable Writeoff After Recovery To Average Outstanding Percent FinancingReceivableWriteoffAfterRecoveryToAverageOutstandingPercent	0.10	pure
CY2021	scnd	Granted Options GrantedOptions	1094171	shares
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	268848	usd
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	7929600	usd
CY2022	scnd	Granted Options GrantedOptions	60000	shares
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0191	pure
CY2021	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0140	pure
CY2022	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	0.72	pure
CY2021	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	0.66	pure
CY2022	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0	pure
CY2021	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0	pure
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350600	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2108000	usd
CY2022	scnd	Nonvested Awards Expected To Be Recognized NonvestedAwardsExpectedToBeRecognized	3187300	usd
CY2021	scnd	Nonvested Awards Expected To Be Recognized NonvestedAwardsExpectedToBeRecognized	5935000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y6M3D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y3M7D
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	297900	usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2022	scnd	Employees Deferral Over EmployeesDeferralOver	0.03	pure
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	24900	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1180757	shares
CY2021Q2	scnd	Weighted Average Exercise Price Outstanding Beginning WeightedAverageExercisePriceOutstandingBeginning	8.73
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96586	shares
CY2020Q2	scnd	Weighted Average Exercise Price Outstanding Beginning WeightedAverageExercisePriceOutstandingBeginning	4.35
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	120000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.78
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1094171	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.07
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	scnd	Number Of Options Exercised NumberOfOptionsExercised	-1000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.05
CY2022	scnd	Number Of Options Forfeited NumberOfOptionsForfeited	-142113	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.98
CY2021	scnd	Number Of Options Forfeited NumberOfOptionsForfeited	-9000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.11
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1158644	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.40
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1180757	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.73
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	567594	shares
CY2022Q2	scnd	Weighted Average Exercise Price Exercisable WeightedAverageExercisePriceExercisable	8.13
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	296821	shares
CY2021Q2	scnd	Weighted Average Exercise Price Exercisable WeightedAverageExercisePriceExercisable	7.69
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.43
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.25
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1158644	shares
CY2022Q2	scnd	Number Of Options Exercisable NumberOfOptionsExercisable	567594	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1180757	shares
CY2021Q2	scnd	Number Of Options Exercisable NumberOfOptionsExercisable	296821	shares
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	715500	usd
CY2022Q2	scnd	Deferred Tax Asset Acquired DeferredTaxAssetAcquired	800300	usd
CY2021Q2	scnd	Deferred Tax Asset Acquired DeferredTaxAssetAcquired	800300	usd
CY2021	us-gaap	Multiemployer Plan Contribution Rate Increase Decrease MultiemployerPlanContributionRateIncreaseDecrease	0.50	pure
CY2022	us-gaap	Multiemployer Plan Contribution Rate Increase Decrease MultiemployerPlanContributionRateIncreaseDecrease	0.03	pure
CY2021	scnd	Employees Deferral Over EmployeesDeferralOver	0.05	pure
CY2022	us-gaap	Contribution Of Property ContributionOfProperty	112400	usd
CY2021	us-gaap	Contribution Of Property ContributionOfProperty	90700	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1470400	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1014300	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-99200	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-93900	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	64300	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	59500	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	91100	usd
CY2021	us-gaap	Payments For Loans PaymentsForLoans	111700	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	247500	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-7900	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1348900	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1152500	usd
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	326600	usd
CY2021Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	374000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	367400	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	164600	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	50400	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	64600	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	763600	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	383200	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1197400	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3803600	usd
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2527100	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	60000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	37200	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3743600	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2489900	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	5702000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	3407000	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	440000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	405400	usd
CY2021Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	440000	usd
CY2022	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	28500	usd
CY2022Q2	us-gaap	Cash Cash	200	usd
CY2021Q2	us-gaap	Cash Cash	0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	0	usd
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	52000	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory1 DisposalGroupIncludingDiscontinuedOperationInventory1	0	usd
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory1 DisposalGroupIncludingDiscontinuedOperationInventory1	3300	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	200	usd
CY2021Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	55300	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities	0	usd
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities	20700	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	0	usd
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	16500	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2021Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	37200	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	28500	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	387700	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	16600	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	471800	usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	11900	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-84100	usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	3500	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	280400	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	8400	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-364500	usd
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	usd
CY2021	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-405400	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	8400	usd
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-769900	usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4000	usd
CY2021	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-207400	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4400	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-562500	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	17800	usd
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-75000	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	440000	usd

Files In Submission

Name	View Source	Status
0001654954-22-013054-index-headers.html	Edgar Link	pending
0001654954-22-013054-index.html	Edgar Link	pending
0001654954-22-013054.txt	Edgar Link	pending
0001654954-22-013054-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scnd-20220630.xsd	Edgar Link	pending
scnd_10k.htm	Edgar Link	pending
scnd-20220630_lab.xml	Edgar Link	unprocessable
scnd-20220630_pre.xml	Edgar Link	unprocessable
scnd-20220630_def.xml	Edgar Link	unprocessable
scnd_10k_htm.xml	Edgar Link	completed
scnd_ex231.htm	Edgar Link	pending
scnd_ex311.htm	Edgar Link	pending
scnd_ex312.htm	Edgar Link	pending
scnd_ex321.htm	Edgar Link	pending
scnd_ex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending
scnd-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

2022 Q3 Form 10-K Financial Statement

#000165495422013054 Filed on September 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND SCIENTIFIC INDUSTRIES INC Stock $scnd

2022 Q3 Form 10-K Financial Statement

#000165495422013054 Filed on September 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd